Alzheimer’s disease (AD) results from a combination of abnormal protein buildup in the brain, genetic factors, lifestyle influences, and aging itself. No single cause explains every case, but the interplay of these factors damages brain cells over years or even decades before symptoms appear. About 6.9 million Americans age 65 and older currently live with Alzheimer’s dementia, and the risk rises steeply with age.
Protein Buildup in the Brain
Two types of abnormal protein deposits define Alzheimer’s at the cellular level: amyloid plaques and tau tangles. A protein called beta-amyloid, which forms naturally when a larger protein breaks down, begins clumping between brain cells. One form, beta-amyloid 42, is especially toxic. These clumps, or plaques, disrupt how cells communicate and function.
Inside neurons, a separate problem unfolds. A protein called tau normally acts like scaffolding, stabilizing the internal transport system that moves nutrients through each cell. In Alzheimer’s, tau detaches from this scaffolding, sticks to other tau molecules, and forms tangled threads inside neurons. These tangles block the cell’s transport system, choking off communication between neurons. Tau tangles tend to accumulate first in brain regions involved in memory, then spread rapidly once amyloid plaque levels reach a tipping point.
How Brain Cells Lose Their Signaling Power
The chemical messenger acetylcholine plays a central role in memory and learning. In Alzheimer’s, the neurons that produce acetylcholine, particularly those deep in the base of the brain, degenerate severely. As these cells die off, acetylcholine levels plummet, and the enzyme that helps produce it becomes significantly less active. The degree of cognitive decline tracks closely with the loss of connections between these deep brain cells and the hippocampus and cortex, the regions responsible for forming and storing memories.
The Brain’s Immune Response Backfires
The brain has its own immune cells, called microglia, that normally patrol for damage and clear debris. When amyloid plaques first appear, microglia activate and try to consume them. This initial response is protective. But prolonged activation flips these cells into a damaging state. They lose their ability to clear amyloid and instead release inflammatory molecules that harm neurons directly.
This chronic inflammation becomes a self-reinforcing cycle: activated immune cells release compounds that damage the blood-brain barrier, which allows even more immune activity into brain tissue, which triggers further inflammation. The result is accelerated accumulation of both amyloid plaques and tau tangles, along with progressive loss of synapses and neurons. Neuroinflammation is now considered one of the core hallmarks of the disease, alongside the protein deposits themselves.
Age Is the Strongest Risk Factor
Alzheimer’s risk roughly doubles with each decade after 65. About 5% of people between 65 and 74 have Alzheimer’s dementia, rising to 13.2% of those 75 to 84, and a striking 33.4% of people 85 and older. The rate of new diagnoses follows the same curve: each year, roughly 4 out of every 1,000 people aged 65 to 74 develop Alzheimer’s, compared to 76 out of every 1,000 people over 85.
Age-related changes in blood flow, the brain’s waste-clearing systems, and the ability to repair cellular damage all contribute. These processes slow down naturally over time, giving toxic proteins more opportunity to accumulate.
Genetic Causes and Risk Genes
Genetics play two distinct roles in Alzheimer’s, depending on whether the disease strikes early or late in life.
Early-Onset Alzheimer’s
About 5% of Alzheimer’s patients develop symptoms before age 65. Of these, roughly 10 to 15% carry a mutation in one of three genes: APP, PSEN1, or PSEN2. The APP gene provides the blueprint for amyloid precursor protein, the molecule that gets broken down into toxic beta-amyloid. PSEN1 and PSEN2 encode parts of the enzyme that does the cutting. Mutations in any of these genes lead to either more amyloid production or a higher proportion of the especially toxic amyloid 42 form. These mutations are inherited in a dominant pattern, meaning a single copy from one parent is enough to cause the disease, often beginning as early as the 30s or 40s with an aggressive course.
Late-Onset Alzheimer’s
The vast majority of cases begin after 65 and involve a different kind of genetic influence. The APOE gene comes in several variants, and one version, APOE4, significantly raises risk. People who carry two copies of APOE4 (about 2% of the general population) have an estimated 60% chance of developing Alzheimer’s dementia by age 85. Despite being a small fraction of the population, they account for roughly 15% of all Alzheimer’s cases. Carrying APOE4 doesn’t guarantee the disease, but it shifts the odds considerably and may also influence the severity of neuropsychiatric symptoms.
Blood Flow and Insulin Resistance
The brain consumes enormous amounts of glucose, and insulin plays a key role in getting that fuel where it needs to go. Insulin crosses from the bloodstream into the brain through specialized receptors and stimulates the transporters that move glucose into neurons. When the body becomes insulin resistant, this system breaks down in several ways. Blood flow to the brain decreases. The blood-brain barrier becomes more permeable. And neurons can no longer take up glucose efficiently, starving them of the energy they need for memory and cognition.
Research in cognitively healthy middle-aged adults has shown that insulin resistance is already associated with lower arterial blood flow to the brain and reduced glucose metabolism in cortical tissue. These metabolic deficits predict worse memory performance even before any clinical signs of dementia appear, suggesting that vascular and metabolic damage may set the stage for Alzheimer’s years in advance.
Modifiable Lifestyle Factors
A 2024 Lancet Commission report identified 14 modifiable risk factors that collectively account for a meaningful share of dementia cases worldwide. These include less education, hearing loss, high blood pressure, smoking, obesity, depression, physical inactivity, diabetes, excessive alcohol consumption (more than 12 standard US drinks per week), traumatic brain injury, air pollution, social isolation, untreated vision loss, and high LDL cholesterol. The last two were added based on newly compelling evidence.
Environmental exposures compound these risks. Exposure to nitrogen dioxide, nitrogen oxides, and fine particulate matter (PM2.5) each raise dementia risk by about 5 to 7% per standard deviation increase in concentration. These pollutants also interact with lifestyle factors: people who are physically inactive, sleep poorly, or smoke face amplified risk when also exposed to higher air pollution levels. A UK Biobank study found that low physical activity raised dementia risk by 17%, poor sleep patterns by 13%, and smoking by 14%, with joint effects when these factors overlap with pollutant exposure.
Sleep quality deserves particular attention because the brain’s waste-clearing system is most active during sleep. Poor or fragmented sleep may reduce the brain’s ability to flush out beta-amyloid and other metabolic waste, allowing toxic proteins to accumulate faster.
How These Causes Work Together
Alzheimer’s is rarely the result of a single broken mechanism. In most people, the disease emerges from overlapping failures. Genetic susceptibility may lower the threshold at which amyloid begins to accumulate. Vascular damage from high blood pressure or diabetes reduces the brain’s ability to clear that amyloid. Chronic inflammation from overactive immune cells accelerates the spread of tau. And lifestyle factors like inactivity, poor sleep, and social isolation remove the protective buffers that might otherwise slow the process.
This layered model explains why the disease varies so much from person to person. Someone with strong genetic risk but excellent cardiovascular health and an active social life may develop symptoms much later, or not at all, compared to someone with moderate genetic risk but multiple lifestyle and metabolic risk factors stacking against them.